OmniSeq Overview

  • Founded
  • 2015
  • Status
  • Private
  • Employees
  • 55
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $1.57M
Latest Deal Amount
  • Investors
  • 2

OmniSeq General Information


Developer of molecular therapy technologies designed to improve access and better cancer treatment options through comprehensive molecular profiling. The company's molecular therapy technologies consist of a platform known as OmniSeq Target which is a differentiated cancer diagnostic that leverages dual next-generation sequencing (dual NGS) and a proprietary algorithm that resolves inconsistencies in solid tumor identification, yielding highly accurate results with essentially no false positives and focuses on precision, connectivity and collaboration, enabling cancer patients to get treatment through advanced and accurate therapeutic technologies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Outcome Management (Healthcare)
Primary Office
  • 700 Ellicott Street
  • Buffalo, NY 14203
  • United States
+1 (800) 000-0000

OmniSeq Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OmniSeq Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 20-Jun-2019 $1.57M 000.00 Completed Startup
2. Corporate (Series B) 02-May-2019 000.00 000.00 Completed Generating Revenue
1. Corporate 17-Jun-2015 $20M $20M Completed Generating Revenue
To view OmniSeq’s complete valuation and funding history, request access »

OmniSeq Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of molecular therapy technologies designed to improve access and better cancer treatment options through compr
Diagnostic Equipment
Buffalo, NY
55 As of 2020
0000000000 000.00


n ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
0000000000 000000000
Irvine, CA
000 As of 0000
000000000 - 00000


ectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
0000000000 000000000
Toronto, Canada
00 As of 0000
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OmniSeq Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agendia Private Equity-Backed Irvine, CA 000 00000 000000000 - 00000
00000000 Venture Capital-Backed Toronto, Canada 00 0000 00000000000 0000
000000000000000 Formerly VC-backed San Diego, CA 000 000.00 000000&0 000.00
00000000000 Venture Capital-Backed Birmingham, AL 00 00.000 0000000000 0 00.000
000000000 Venture Capital-Backed Boulder, CO 000 000.00 00000000000 000.00
You’re viewing 5 of 18 competitors. Get the full list »

OmniSeq Executive Team (6)

Name Title Board Seat Contact Info
Mark Gardner Chief Executive Officer & Board Member
Candace Johnson Ph.D Chief Executive Officer
Carl Morrison MD President, Chief Scientific Officer, Founder and Board Member
Margot Schoenborn JD Chief Administrative Officer, General Counsel, Compliance and Privacy Officer & Corporate Secretary
Matt Klusas Chief Commercial Officer
You’re viewing 5 of 6 executive team members. Get the full list »

OmniSeq Board Members (6)

Name Representing Role Since
Buford Sears OmniSeq Board Member 000 0000
Kenneth Manning OmniSeq Board Member 000 0000
Marcia Eisenberg Self Board Member 000 0000
Mark Gardner OmniSeq Chief Executive Officer & Board Member 000 0000
Paul Billings Ph.D OmniSeq Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

OmniSeq Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OmniSeq Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Laboratory Corporation of America Corporation Minority 000 0000 000000 0
Roswell Park Cancer Institute Corporation Minority 000 0000 000000 0
To view OmniSeq’s complete investors history, request access »